Mucosal Autoimmunity Related News
Breakthrough study links Type 1 diabetes and Sjogren’s syndrome
MEDIA RELEASE:
22 Apr 2011
Garvan scientists have identified a new group of immune cells that for the first time directly link two autoimmune diseases, Type 1 diabetes and Sjogren’s syndrome. Autoimmune diseases arise when the body’s defences become overactive, and instead of attacking invading microbes, it starts to attack itself. In the case of Type 1 diabetes, the body attacks insulin-producing cells in the pancreas. In the case of Sjogren’s syndrome, it attacks its own salivary glands.
Potential anti-rejection drug for insulin cell transplantation
MEDIA RELEASE:
01 Mar 2011
Garvan scientists have developed a reagent with the potential to prevent rejection of transplanted insulin-producing cells into people with Type 1 diabetes – one of the most promising immunology developments in recent years.
The genetic fuse that may ignite Type 1 diabetes
MEDIA RELEASE:
20 Oct 2009
Garvan scientists have discovered that a tiny genetic irregularity, which boosts the expression of a key gene, may lead to the development of Type 1 diabetes. While there is no cure yet, prevention therapies are on the horizon, making the development of reliable screening tools critical. And that's where the current finding has promise.
Garvan immunology students win main prizes at ASI conference
19 Dec 2008
For the second year in a row, a PhD student from Garvan has won the very prestigious New Investigator Award at the annual Australasian Society for Immunology (ASI) conference, held last week in Canberra. The 2008 winner is Alexis Vogelzang.
Immunology in the very blood of Castle Harlan award winner
31 Oct 2008
Helen McGuire has received the $10,000 USD Castle Harlan award for being the most outstanding early career PhD student at the Garvan Institute in 2008. Castle Harlan is a distinguished and philanthropic US-based private equity firm that wishes to support the kind of medical research being undertaken at Garvan.
Finding suggests novel ways to boost vaccination or natural defences
MEDIA RELEASE:
07 Jul 2008
Our bodies rely on the production of potent, or 'high affinity', antibodies to fight infection. The process is very complex, yet Garvan scientists have discovered that it hinges on a single molecule, a growth factor, without which it cannot function. This suggest ways to strengthen the body's natural defences.
